This inactivation of CFIm by hyperphosphorylation also explains how CFIm68 can be highly expressed in human hepatocellular carcinoma, breast cancer, and gastric cancer cells, but still be inactive and result in short 3′UTRs. The gene discussed is CPSF6; the disease is breast carcinoma.